nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—ALB—liver cancer	0.542	1	CbGaD
Oxcarbazepine—CYP3A5—Sorafenib—liver cancer	0.0639	0.411	CbGbCtD
Oxcarbazepine—CYP2C19—Sorafenib—liver cancer	0.0516	0.331	CbGbCtD
Oxcarbazepine—CYP3A4—Sorafenib—liver cancer	0.0249	0.16	CbGbCtD
Oxcarbazepine—CYP3A4—Doxorubicin—liver cancer	0.0151	0.0972	CbGbCtD
Oxcarbazepine—Magnesium salicylate—ALB—liver cancer	0.000465	0.15	CrCbGaD
Oxcarbazepine—Warfarin—CYP1A1—liver cancer	0.000449	0.145	CrCbGaD
Oxcarbazepine—Menopausal symptoms—Doxorubicin—liver cancer	0.000446	0.00189	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Sorafenib—liver cancer	0.000446	0.00189	CcSEcCtD
Oxcarbazepine—Piroxicam—ALB—liver cancer	0.000446	0.144	CrCbGaD
Oxcarbazepine—Purpura—Doxorubicin—liver cancer	0.000437	0.00185	CcSEcCtD
Oxcarbazepine—Asthenia—Sorafenib—liver cancer	0.000434	0.00184	CcSEcCtD
Oxcarbazepine—Hypoglycaemia—Doxorubicin—liver cancer	0.000431	0.00183	CcSEcCtD
Oxcarbazepine—Cardiac failure—Doxorubicin—liver cancer	0.000431	0.00183	CcSEcCtD
Oxcarbazepine—Mood swings—Epirubicin—liver cancer	0.000431	0.00182	CcSEcCtD
Oxcarbazepine—Lethargy—Doxorubicin—liver cancer	0.00043	0.00182	CcSEcCtD
Oxcarbazepine—Pruritus—Sorafenib—liver cancer	0.000428	0.00181	CcSEcCtD
Oxcarbazepine—Ataxia—Epirubicin—liver cancer	0.000428	0.00181	CcSEcCtD
Oxcarbazepine—Hyponatraemia—Doxorubicin—liver cancer	0.000423	0.00179	CcSEcCtD
Oxcarbazepine—Pain in extremity—Doxorubicin—liver cancer	0.000421	0.00178	CcSEcCtD
Oxcarbazepine—Diplopia—Doxorubicin—liver cancer	0.000421	0.00178	CcSEcCtD
Oxcarbazepine—Liver function test abnormal—Epirubicin—liver cancer	0.00042	0.00178	CcSEcCtD
Oxcarbazepine—Abdominal pain upper—Epirubicin—liver cancer	0.000416	0.00176	CcSEcCtD
Oxcarbazepine—Orthostatic hypotension—Epirubicin—liver cancer	0.000416	0.00176	CcSEcCtD
Oxcarbazepine—Migraine—Doxorubicin—liver cancer	0.000414	0.00175	CcSEcCtD
Oxcarbazepine—Affect lability—Doxorubicin—liver cancer	0.000414	0.00175	CcSEcCtD
Oxcarbazepine—Hypokalaemia—Epirubicin—liver cancer	0.000414	0.00175	CcSEcCtD
Oxcarbazepine—Diarrhoea—Sorafenib—liver cancer	0.000414	0.00175	CcSEcCtD
Oxcarbazepine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00041	0.00173	CcSEcCtD
Oxcarbazepine—Nasopharyngitis—Epirubicin—liver cancer	0.000407	0.00172	CcSEcCtD
Oxcarbazepine—Gastritis—Epirubicin—liver cancer	0.000403	0.0017	CcSEcCtD
Oxcarbazepine—Muscular weakness—Epirubicin—liver cancer	0.000401	0.0017	CcSEcCtD
Oxcarbazepine—Dizziness—Sorafenib—liver cancer	0.0004	0.00169	CcSEcCtD
Oxcarbazepine—Mood swings—Doxorubicin—liver cancer	0.000399	0.00169	CcSEcCtD
Oxcarbazepine—Ataxia—Doxorubicin—liver cancer	0.000396	0.00167	CcSEcCtD
Oxcarbazepine—Asthma—Epirubicin—liver cancer	0.000393	0.00166	CcSEcCtD
Oxcarbazepine—Dysphagia—Epirubicin—liver cancer	0.000393	0.00166	CcSEcCtD
Oxcarbazepine—Eosinophilia—Epirubicin—liver cancer	0.000389	0.00165	CcSEcCtD
Oxcarbazepine—Liver function test abnormal—Doxorubicin—liver cancer	0.000389	0.00164	CcSEcCtD
Oxcarbazepine—Pancreatitis—Epirubicin—liver cancer	0.000386	0.00163	CcSEcCtD
Oxcarbazepine—Vomiting—Sorafenib—liver cancer	0.000385	0.00163	CcSEcCtD
Oxcarbazepine—Abdominal pain upper—Doxorubicin—liver cancer	0.000385	0.00163	CcSEcCtD
Oxcarbazepine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000385	0.00163	CcSEcCtD
Oxcarbazepine—Hypokalaemia—Doxorubicin—liver cancer	0.000383	0.00162	CcSEcCtD
Oxcarbazepine—Rash—Sorafenib—liver cancer	0.000382	0.00161	CcSEcCtD
Oxcarbazepine—Dermatitis—Sorafenib—liver cancer	0.000381	0.00161	CcSEcCtD
Oxcarbazepine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000379	0.0016	CcSEcCtD
Oxcarbazepine—Headache—Sorafenib—liver cancer	0.000379	0.0016	CcSEcCtD
Oxcarbazepine—Bronchitis—Epirubicin—liver cancer	0.000378	0.0016	CcSEcCtD
Oxcarbazepine—Nasopharyngitis—Doxorubicin—liver cancer	0.000377	0.00159	CcSEcCtD
Oxcarbazepine—Pancytopenia—Epirubicin—liver cancer	0.000374	0.00158	CcSEcCtD
Oxcarbazepine—Gastritis—Doxorubicin—liver cancer	0.000373	0.00158	CcSEcCtD
Oxcarbazepine—Muscular weakness—Doxorubicin—liver cancer	0.000371	0.00157	CcSEcCtD
Oxcarbazepine—Neutropenia—Epirubicin—liver cancer	0.000368	0.00156	CcSEcCtD
Oxcarbazepine—Dysuria—Epirubicin—liver cancer	0.000368	0.00156	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Epirubicin—liver cancer	0.000366	0.00155	CcSEcCtD
Oxcarbazepine—Dysphagia—Doxorubicin—liver cancer	0.000364	0.00154	CcSEcCtD
Oxcarbazepine—Asthma—Doxorubicin—liver cancer	0.000364	0.00154	CcSEcCtD
Oxcarbazepine—Pollakiuria—Epirubicin—liver cancer	0.000363	0.00154	CcSEcCtD
Oxcarbazepine—Eosinophilia—Doxorubicin—liver cancer	0.00036	0.00152	CcSEcCtD
Oxcarbazepine—Nausea—Sorafenib—liver cancer	0.000359	0.00152	CcSEcCtD
Oxcarbazepine—Photosensitivity reaction—Epirubicin—liver cancer	0.000359	0.00152	CcSEcCtD
Oxcarbazepine—Weight increased—Epirubicin—liver cancer	0.000358	0.00151	CcSEcCtD
Oxcarbazepine—Pancreatitis—Doxorubicin—liver cancer	0.000357	0.00151	CcSEcCtD
Oxcarbazepine—Weight decreased—Epirubicin—liver cancer	0.000356	0.00151	CcSEcCtD
Oxcarbazepine—Hyperglycaemia—Epirubicin—liver cancer	0.000355	0.0015	CcSEcCtD
Oxcarbazepine—Pneumonia—Epirubicin—liver cancer	0.000353	0.00149	CcSEcCtD
Oxcarbazepine—Infestation—Epirubicin—liver cancer	0.000351	0.00148	CcSEcCtD
Oxcarbazepine—Infestation NOS—Epirubicin—liver cancer	0.000351	0.00148	CcSEcCtD
Oxcarbazepine—Bronchitis—Doxorubicin—liver cancer	0.00035	0.00148	CcSEcCtD
Oxcarbazepine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000348	0.00147	CcSEcCtD
Oxcarbazepine—Pancytopenia—Doxorubicin—liver cancer	0.000346	0.00146	CcSEcCtD
Oxcarbazepine—Renal failure—Epirubicin—liver cancer	0.000345	0.00146	CcSEcCtD
Oxcarbazepine—Stomatitis—Epirubicin—liver cancer	0.000342	0.00145	CcSEcCtD
Oxcarbazepine—Urinary tract infection—Epirubicin—liver cancer	0.000341	0.00144	CcSEcCtD
Oxcarbazepine—Dysuria—Doxorubicin—liver cancer	0.00034	0.00144	CcSEcCtD
Oxcarbazepine—Neutropenia—Doxorubicin—liver cancer	0.00034	0.00144	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000338	0.00143	CcSEcCtD
Oxcarbazepine—Pollakiuria—Doxorubicin—liver cancer	0.000336	0.00142	CcSEcCtD
Oxcarbazepine—Haematuria—Epirubicin—liver cancer	0.000334	0.00141	CcSEcCtD
Oxcarbazepine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000332	0.00141	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Epirubicin—liver cancer	0.000332	0.0014	CcSEcCtD
Oxcarbazepine—Weight increased—Doxorubicin—liver cancer	0.000331	0.0014	CcSEcCtD
Oxcarbazepine—Epistaxis—Epirubicin—liver cancer	0.000331	0.0014	CcSEcCtD
Oxcarbazepine—Weight decreased—Doxorubicin—liver cancer	0.000329	0.00139	CcSEcCtD
Oxcarbazepine—Sinusitis—Epirubicin—liver cancer	0.000329	0.00139	CcSEcCtD
Oxcarbazepine—Hyperglycaemia—Doxorubicin—liver cancer	0.000328	0.00139	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Epirubicin—liver cancer	0.000327	0.00138	CcSEcCtD
Oxcarbazepine—Pneumonia—Doxorubicin—liver cancer	0.000326	0.00138	CcSEcCtD
Oxcarbazepine—Infestation—Doxorubicin—liver cancer	0.000324	0.00137	CcSEcCtD
Oxcarbazepine—Infestation NOS—Doxorubicin—liver cancer	0.000324	0.00137	CcSEcCtD
Oxcarbazepine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000322	0.00136	CcSEcCtD
Oxcarbazepine—Bradycardia—Epirubicin—liver cancer	0.000321	0.00136	CcSEcCtD
Oxcarbazepine—Renal failure—Doxorubicin—liver cancer	0.000319	0.00135	CcSEcCtD
Oxcarbazepine—Stomatitis—Doxorubicin—liver cancer	0.000316	0.00134	CcSEcCtD
Oxcarbazepine—Rhinitis—Epirubicin—liver cancer	0.000316	0.00134	CcSEcCtD
Oxcarbazepine—Urinary tract infection—Doxorubicin—liver cancer	0.000315	0.00133	CcSEcCtD
Oxcarbazepine—Hepatitis—Epirubicin—liver cancer	0.000315	0.00133	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Epirubicin—liver cancer	0.000313	0.00133	CcSEcCtD
Oxcarbazepine—Pharyngitis—Epirubicin—liver cancer	0.000312	0.00132	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Epirubicin—liver cancer	0.00031	0.00131	CcSEcCtD
Oxcarbazepine—Haematuria—Doxorubicin—liver cancer	0.000309	0.00131	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000307	0.0013	CcSEcCtD
Oxcarbazepine—Epistaxis—Doxorubicin—liver cancer	0.000306	0.00129	CcSEcCtD
Oxcarbazepine—Sinusitis—Doxorubicin—liver cancer	0.000304	0.00129	CcSEcCtD
Oxcarbazepine—Visual impairment—Epirubicin—liver cancer	0.000303	0.00128	CcSEcCtD
Oxcarbazepine—Agranulocytosis—Doxorubicin—liver cancer	0.000303	0.00128	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Epirubicin—liver cancer	0.000298	0.00126	CcSEcCtD
Oxcarbazepine—Bradycardia—Doxorubicin—liver cancer	0.000297	0.00125	CcSEcCtD
Oxcarbazepine—Eye disorder—Epirubicin—liver cancer	0.000294	0.00124	CcSEcCtD
Oxcarbazepine—Tinnitus—Epirubicin—liver cancer	0.000294	0.00124	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Epirubicin—liver cancer	0.000292	0.00124	CcSEcCtD
Oxcarbazepine—Flushing—Epirubicin—liver cancer	0.000292	0.00124	CcSEcCtD
Oxcarbazepine—Rhinitis—Doxorubicin—liver cancer	0.000292	0.00124	CcSEcCtD
Oxcarbazepine—Hepatitis—Doxorubicin—liver cancer	0.000291	0.00123	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Doxorubicin—liver cancer	0.00029	0.00123	CcSEcCtD
Oxcarbazepine—Pharyngitis—Doxorubicin—liver cancer	0.000289	0.00122	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Doxorubicin—liver cancer	0.000287	0.00121	CcSEcCtD
Oxcarbazepine—Angiopathy—Epirubicin—liver cancer	0.000286	0.00121	CcSEcCtD
Oxcarbazepine—Immune system disorder—Epirubicin—liver cancer	0.000284	0.0012	CcSEcCtD
Oxcarbazepine—Chills—Epirubicin—liver cancer	0.000282	0.00119	CcSEcCtD
Oxcarbazepine—Arrhythmia—Epirubicin—liver cancer	0.000281	0.00119	CcSEcCtD
Oxcarbazepine—Visual impairment—Doxorubicin—liver cancer	0.000281	0.00119	CcSEcCtD
Oxcarbazepine—Nortriptyline—CYP2E1—liver cancer	0.00028	0.0904	CrCbGaD
Oxcarbazepine—Alopecia—Epirubicin—liver cancer	0.000278	0.00118	CcSEcCtD
Oxcarbazepine—Mental disorder—Epirubicin—liver cancer	0.000276	0.00117	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Doxorubicin—liver cancer	0.000275	0.00117	CcSEcCtD
Oxcarbazepine—Malnutrition—Epirubicin—liver cancer	0.000274	0.00116	CcSEcCtD
Oxcarbazepine—Eye disorder—Doxorubicin—liver cancer	0.000272	0.00115	CcSEcCtD
Oxcarbazepine—Tinnitus—Doxorubicin—liver cancer	0.000272	0.00115	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Doxorubicin—liver cancer	0.00027	0.00114	CcSEcCtD
Oxcarbazepine—Flushing—Doxorubicin—liver cancer	0.00027	0.00114	CcSEcCtD
Oxcarbazepine—Flatulence—Epirubicin—liver cancer	0.00027	0.00114	CcSEcCtD
Oxcarbazepine—Tension—Epirubicin—liver cancer	0.000269	0.00114	CcSEcCtD
Oxcarbazepine—Dysgeusia—Epirubicin—liver cancer	0.000268	0.00114	CcSEcCtD
Oxcarbazepine—Nervousness—Epirubicin—liver cancer	0.000266	0.00113	CcSEcCtD
Oxcarbazepine—Back pain—Epirubicin—liver cancer	0.000265	0.00112	CcSEcCtD
Oxcarbazepine—Angiopathy—Doxorubicin—liver cancer	0.000264	0.00112	CcSEcCtD
Oxcarbazepine—Immune system disorder—Doxorubicin—liver cancer	0.000263	0.00111	CcSEcCtD
Oxcarbazepine—Chills—Doxorubicin—liver cancer	0.000261	0.00111	CcSEcCtD
Oxcarbazepine—Arrhythmia—Doxorubicin—liver cancer	0.00026	0.0011	CcSEcCtD
Oxcarbazepine—Vision blurred—Epirubicin—liver cancer	0.000258	0.00109	CcSEcCtD
Oxcarbazepine—Alopecia—Doxorubicin—liver cancer	0.000257	0.00109	CcSEcCtD
Oxcarbazepine—Mental disorder—Doxorubicin—liver cancer	0.000255	0.00108	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Epirubicin—liver cancer	0.000254	0.00108	CcSEcCtD
Oxcarbazepine—Malnutrition—Doxorubicin—liver cancer	0.000254	0.00107	CcSEcCtD
Oxcarbazepine—Agitation—Epirubicin—liver cancer	0.000252	0.00107	CcSEcCtD
Oxcarbazepine—Flatulence—Doxorubicin—liver cancer	0.00025	0.00106	CcSEcCtD
Oxcarbazepine—Warfarin—ALB—liver cancer	0.00025	0.0807	CrCbGaD
Oxcarbazepine—Tension—Doxorubicin—liver cancer	0.000249	0.00105	CcSEcCtD
Oxcarbazepine—Dysgeusia—Doxorubicin—liver cancer	0.000248	0.00105	CcSEcCtD
Oxcarbazepine—Malaise—Epirubicin—liver cancer	0.000247	0.00105	CcSEcCtD
Oxcarbazepine—Nervousness—Doxorubicin—liver cancer	0.000246	0.00104	CcSEcCtD
Oxcarbazepine—Vertigo—Epirubicin—liver cancer	0.000246	0.00104	CcSEcCtD
Oxcarbazepine—Syncope—Epirubicin—liver cancer	0.000246	0.00104	CcSEcCtD
Oxcarbazepine—Leukopenia—Epirubicin—liver cancer	0.000245	0.00104	CcSEcCtD
Oxcarbazepine—Back pain—Doxorubicin—liver cancer	0.000245	0.00104	CcSEcCtD
Oxcarbazepine—Palpitations—Epirubicin—liver cancer	0.000242	0.00102	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Epirubicin—liver cancer	0.000241	0.00102	CcSEcCtD
Oxcarbazepine—Cough—Epirubicin—liver cancer	0.000239	0.00101	CcSEcCtD
Oxcarbazepine—Vision blurred—Doxorubicin—liver cancer	0.000239	0.00101	CcSEcCtD
Oxcarbazepine—Convulsion—Epirubicin—liver cancer	0.000237	0.001	CcSEcCtD
Oxcarbazepine—Hypertension—Epirubicin—liver cancer	0.000237	0.001	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Doxorubicin—liver cancer	0.000235	0.000995	CcSEcCtD
Oxcarbazepine—Arthralgia—Epirubicin—liver cancer	0.000233	0.000987	CcSEcCtD
Oxcarbazepine—Myalgia—Epirubicin—liver cancer	0.000233	0.000987	CcSEcCtD
Oxcarbazepine—Chest pain—Epirubicin—liver cancer	0.000233	0.000987	CcSEcCtD
Oxcarbazepine—Agitation—Doxorubicin—liver cancer	0.000233	0.000986	CcSEcCtD
Oxcarbazepine—Anxiety—Epirubicin—liver cancer	0.000233	0.000984	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000232	0.00098	CcSEcCtD
Oxcarbazepine—Discomfort—Epirubicin—liver cancer	0.000231	0.000975	CcSEcCtD
Oxcarbazepine—Desipramine—CYP2E1—liver cancer	0.00023	0.0744	CrCbGaD
Oxcarbazepine—Malaise—Doxorubicin—liver cancer	0.000229	0.000967	CcSEcCtD
Oxcarbazepine—Dry mouth—Epirubicin—liver cancer	0.000228	0.000965	CcSEcCtD
Oxcarbazepine—Vertigo—Doxorubicin—liver cancer	0.000228	0.000964	CcSEcCtD
Oxcarbazepine—Syncope—Doxorubicin—liver cancer	0.000227	0.000962	CcSEcCtD
Oxcarbazepine—Leukopenia—Doxorubicin—liver cancer	0.000227	0.00096	CcSEcCtD
Oxcarbazepine—Confusional state—Epirubicin—liver cancer	0.000226	0.000954	CcSEcCtD
Oxcarbazepine—Palpitations—Doxorubicin—liver cancer	0.000224	0.000948	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Epirubicin—liver cancer	0.000224	0.000946	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Doxorubicin—liver cancer	0.000223	0.000943	CcSEcCtD
Oxcarbazepine—Infection—Epirubicin—liver cancer	0.000222	0.00094	CcSEcCtD
Oxcarbazepine—Cough—Doxorubicin—liver cancer	0.000221	0.000936	CcSEcCtD
Oxcarbazepine—Shock—Epirubicin—liver cancer	0.00022	0.000931	CcSEcCtD
Oxcarbazepine—Convulsion—Doxorubicin—liver cancer	0.00022	0.000929	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Epirubicin—liver cancer	0.000219	0.000928	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Epirubicin—liver cancer	0.000219	0.000926	CcSEcCtD
Oxcarbazepine—Hypertension—Doxorubicin—liver cancer	0.000219	0.000926	CcSEcCtD
Oxcarbazepine—Tachycardia—Epirubicin—liver cancer	0.000218	0.000923	CcSEcCtD
Oxcarbazepine—Skin disorder—Epirubicin—liver cancer	0.000217	0.000919	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Epirubicin—liver cancer	0.000216	0.000915	CcSEcCtD
Oxcarbazepine—Myalgia—Doxorubicin—liver cancer	0.000216	0.000913	CcSEcCtD
Oxcarbazepine—Chest pain—Doxorubicin—liver cancer	0.000216	0.000913	CcSEcCtD
Oxcarbazepine—Arthralgia—Doxorubicin—liver cancer	0.000216	0.000913	CcSEcCtD
Oxcarbazepine—Anxiety—Doxorubicin—liver cancer	0.000215	0.00091	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000214	0.000907	CcSEcCtD
Oxcarbazepine—Discomfort—Doxorubicin—liver cancer	0.000213	0.000902	CcSEcCtD
Oxcarbazepine—Anorexia—Epirubicin—liver cancer	0.000213	0.000902	CcSEcCtD
Oxcarbazepine—Diazepam—CYP2E1—liver cancer	0.000212	0.0683	CrCbGaD
Oxcarbazepine—Dry mouth—Doxorubicin—liver cancer	0.000211	0.000893	CcSEcCtD
Oxcarbazepine—Hypotension—Epirubicin—liver cancer	0.000209	0.000884	CcSEcCtD
Oxcarbazepine—Confusional state—Doxorubicin—liver cancer	0.000209	0.000883	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Doxorubicin—liver cancer	0.000207	0.000875	CcSEcCtD
Oxcarbazepine—Infection—Doxorubicin—liver cancer	0.000206	0.00087	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000204	0.000862	CcSEcCtD
Oxcarbazepine—Shock—Doxorubicin—liver cancer	0.000204	0.000861	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Doxorubicin—liver cancer	0.000203	0.000859	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Doxorubicin—liver cancer	0.000203	0.000857	CcSEcCtD
Oxcarbazepine—Insomnia—Epirubicin—liver cancer	0.000202	0.000856	CcSEcCtD
Oxcarbazepine—Tachycardia—Doxorubicin—liver cancer	0.000202	0.000854	CcSEcCtD
Oxcarbazepine—Skin disorder—Doxorubicin—liver cancer	0.000201	0.00085	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Doxorubicin—liver cancer	0.0002	0.000846	CcSEcCtD
Oxcarbazepine—Dyspnoea—Epirubicin—liver cancer	0.000199	0.000844	CcSEcCtD
Oxcarbazepine—Somnolence—Epirubicin—liver cancer	0.000199	0.000841	CcSEcCtD
Oxcarbazepine—Anorexia—Doxorubicin—liver cancer	0.000197	0.000834	CcSEcCtD
Oxcarbazepine—Dyspepsia—Epirubicin—liver cancer	0.000197	0.000833	CcSEcCtD
Oxcarbazepine—Imipramine—CYP2E1—liver cancer	0.000195	0.0631	CrCbGaD
Oxcarbazepine—Decreased appetite—Epirubicin—liver cancer	0.000194	0.000822	CcSEcCtD
Oxcarbazepine—Amitriptyline—CYP2E1—liver cancer	0.000194	0.0627	CrCbGaD
Oxcarbazepine—Hypotension—Doxorubicin—liver cancer	0.000193	0.000818	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000193	0.000817	CcSEcCtD
Oxcarbazepine—Fatigue—Epirubicin—liver cancer	0.000193	0.000816	CcSEcCtD
Oxcarbazepine—Constipation—Epirubicin—liver cancer	0.000191	0.000809	CcSEcCtD
Oxcarbazepine—Pain—Epirubicin—liver cancer	0.000191	0.000809	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000189	0.000798	CcSEcCtD
Oxcarbazepine—Insomnia—Doxorubicin—liver cancer	0.000187	0.000792	CcSEcCtD
Oxcarbazepine—Dyspnoea—Doxorubicin—liver cancer	0.000185	0.00078	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Epirubicin—liver cancer	0.000184	0.00078	CcSEcCtD
Oxcarbazepine—Somnolence—Doxorubicin—liver cancer	0.000184	0.000778	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Epirubicin—liver cancer	0.000183	0.000774	CcSEcCtD
Oxcarbazepine—Dyspepsia—Doxorubicin—liver cancer	0.000182	0.000771	CcSEcCtD
Oxcarbazepine—Decreased appetite—Doxorubicin—liver cancer	0.00018	0.000761	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000179	0.000756	CcSEcCtD
Oxcarbazepine—Fatigue—Doxorubicin—liver cancer	0.000178	0.000755	CcSEcCtD
Oxcarbazepine—Urticaria—Epirubicin—liver cancer	0.000178	0.000752	CcSEcCtD
Oxcarbazepine—Pain—Doxorubicin—liver cancer	0.000177	0.000749	CcSEcCtD
Oxcarbazepine—Constipation—Doxorubicin—liver cancer	0.000177	0.000749	CcSEcCtD
Oxcarbazepine—Body temperature increased—Epirubicin—liver cancer	0.000177	0.000748	CcSEcCtD
Oxcarbazepine—Abdominal pain—Epirubicin—liver cancer	0.000177	0.000748	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Doxorubicin—liver cancer	0.000171	0.000721	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000169	0.000716	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Epirubicin—liver cancer	0.000165	0.000697	CcSEcCtD
Oxcarbazepine—Urticaria—Doxorubicin—liver cancer	0.000164	0.000695	CcSEcCtD
Oxcarbazepine—Abdominal pain—Doxorubicin—liver cancer	0.000164	0.000692	CcSEcCtD
Oxcarbazepine—Body temperature increased—Doxorubicin—liver cancer	0.000164	0.000692	CcSEcCtD
Oxcarbazepine—Asthenia—Epirubicin—liver cancer	0.00016	0.000679	CcSEcCtD
Oxcarbazepine—Pruritus—Epirubicin—liver cancer	0.000158	0.000669	CcSEcCtD
Oxcarbazepine—Nortriptyline—ALB—liver cancer	0.000154	0.0497	CrCbGaD
Oxcarbazepine—Diarrhoea—Epirubicin—liver cancer	0.000153	0.000647	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Doxorubicin—liver cancer	0.000152	0.000645	CcSEcCtD
Oxcarbazepine—Asthenia—Doxorubicin—liver cancer	0.000148	0.000628	CcSEcCtD
Oxcarbazepine—Dizziness—Epirubicin—liver cancer	0.000148	0.000626	CcSEcCtD
Oxcarbazepine—Pruritus—Doxorubicin—liver cancer	0.000146	0.000619	CcSEcCtD
Oxcarbazepine—Vomiting—Epirubicin—liver cancer	0.000142	0.000602	CcSEcCtD
Oxcarbazepine—Diarrhoea—Doxorubicin—liver cancer	0.000142	0.000599	CcSEcCtD
Oxcarbazepine—Rash—Epirubicin—liver cancer	0.000141	0.000597	CcSEcCtD
Oxcarbazepine—Dermatitis—Epirubicin—liver cancer	0.000141	0.000596	CcSEcCtD
Oxcarbazepine—Headache—Epirubicin—liver cancer	0.00014	0.000593	CcSEcCtD
Oxcarbazepine—Dizziness—Doxorubicin—liver cancer	0.000137	0.000579	CcSEcCtD
Oxcarbazepine—Nausea—Epirubicin—liver cancer	0.000133	0.000562	CcSEcCtD
Oxcarbazepine—Vomiting—Doxorubicin—liver cancer	0.000132	0.000557	CcSEcCtD
Oxcarbazepine—Rash—Doxorubicin—liver cancer	0.00013	0.000552	CcSEcCtD
Oxcarbazepine—Dermatitis—Doxorubicin—liver cancer	0.00013	0.000551	CcSEcCtD
Oxcarbazepine—Headache—Doxorubicin—liver cancer	0.00013	0.000548	CcSEcCtD
Oxcarbazepine—Nausea—Doxorubicin—liver cancer	0.000123	0.00052	CcSEcCtD
Oxcarbazepine—Diazepam—ALB—liver cancer	0.000116	0.0375	CrCbGaD
Oxcarbazepine—Amitriptyline—ALB—liver cancer	0.000107	0.0345	CrCbGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	8.1e-05	0.0013	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—KDR—liver cancer	8e-05	0.00128	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	7.98e-05	0.00128	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PRKCE—liver cancer	7.96e-05	0.00127	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—MAPK14—liver cancer	7.95e-05	0.00127	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—MET—liver cancer	7.83e-05	0.00125	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTM1—liver cancer	7.82e-05	0.00125	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTM1—liver cancer	7.71e-05	0.00123	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—NR1H4—liver cancer	7.7e-05	0.00123	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—IL6—liver cancer	7.67e-05	0.00123	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—HPGDS—liver cancer	7.61e-05	0.00122	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—IGF2—liver cancer	7.54e-05	0.00121	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	7.54e-05	0.00121	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP1A1—liver cancer	7.41e-05	0.00119	CbGpPWpGaD
Oxcarbazepine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	7.34e-05	0.00118	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP1A1—liver cancer	7.31e-05	0.00117	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	7.27e-05	0.00116	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—UGDH—liver cancer	7.17e-05	0.00115	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—VEGFA—liver cancer	7.13e-05	0.00114	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—TNF—liver cancer	7.13e-05	0.00114	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—HGF—liver cancer	7.12e-05	0.00114	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—PPARG—liver cancer	7.11e-05	0.00114	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—IL6—liver cancer	7.07e-05	0.00113	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—CSF2—liver cancer	7.04e-05	0.00113	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—MMP9—liver cancer	6.88e-05	0.0011	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—liver cancer	6.79e-05	0.00109	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—EPT1—liver cancer	6.74e-05	0.00108	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—TGFB1—liver cancer	6.55e-05	0.00105	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—MMP2—liver cancer	6.53e-05	0.00105	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—TAT—liver cancer	6.39e-05	0.00102	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—TP53—liver cancer	6.29e-05	0.00101	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—liver cancer	6.24e-05	0.000999	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SERPINA1—liver cancer	6.23e-05	0.000998	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	6.2e-05	0.000993	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	6.19e-05	0.000991	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—VEGFA—liver cancer	6.18e-05	0.000989	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—UGDH—liver cancer	6.17e-05	0.000988	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	6.12e-05	0.000979	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—EPT1—liver cancer	5.8e-05	0.000929	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—RAF1—liver cancer	5.78e-05	0.000926	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—IL6—liver cancer	5.75e-05	0.000921	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—MAPK14—liver cancer	5.7e-05	0.000913	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GGT1—liver cancer	5.69e-05	0.000912	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—TNF—liver cancer	5.66e-05	0.000907	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.56e-05	0.00089	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—UGDH—liver cancer	5.54e-05	0.000887	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—F2—liver cancer	5.53e-05	0.000885	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—TAT—liver cancer	5.5e-05	0.000881	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	5.41e-05	0.000866	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	5.29e-05	0.000847	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—KRAS—liver cancer	5.25e-05	0.000841	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—EPT1—liver cancer	5.21e-05	0.000834	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTP1—liver cancer	5.11e-05	0.000819	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	5.04e-05	0.000808	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—CTNNB1—liver cancer	5.01e-05	0.000802	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—TAT—liver cancer	4.94e-05	0.000791	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—MMP9—liver cancer	4.91e-05	0.000786	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.86e-05	0.000778	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTM1—liver cancer	4.7e-05	0.000752	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	4.65e-05	0.000745	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IFNA1—liver cancer	4.64e-05	0.000743	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	4.64e-05	0.000742	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	4.6e-05	0.000736	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—IL6—liver cancer	4.57e-05	0.000732	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—HRAS—liver cancer	4.46e-05	0.000715	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	4.46e-05	0.000713	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—VEGFA—liver cancer	4.41e-05	0.000706	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	4.39e-05	0.000704	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—STAT3—liver cancer	4.36e-05	0.000699	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GLUL—liver cancer	4.34e-05	0.000695	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CPT1B—liver cancer	4.34e-05	0.000695	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—IL6—liver cancer	4.27e-05	0.000684	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NR1H4—liver cancer	4.19e-05	0.00067	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—RAF1—liver cancer	4.15e-05	0.000665	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTA3—liver cancer	4.12e-05	0.000659	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PRKCE—liver cancer	4.1e-05	0.000657	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	4.05e-05	0.000649	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.05e-05	0.000648	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—TGFB1—liver cancer	4.05e-05	0.000648	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—CYCS—liver cancer	3.92e-05	0.000628	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—ABL1—liver cancer	3.91e-05	0.000625	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IGF2—liver cancer	3.89e-05	0.000623	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—TNF—liver cancer	3.78e-05	0.000605	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTA4—liver cancer	3.77e-05	0.000603	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—KRAS—liver cancer	3.75e-05	0.0006	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GLUL—liver cancer	3.74e-05	0.000599	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CPT1B—liver cancer	3.74e-05	0.000599	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	3.72e-05	0.000596	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—HGF—liver cancer	3.67e-05	0.000588	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTA2—liver cancer	3.67e-05	0.000587	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.64e-05	0.000582	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—CSF2—liver cancer	3.63e-05	0.000581	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NR1H4—liver cancer	3.61e-05	0.000577	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTA3—liver cancer	3.55e-05	0.000568	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTA1—liver cancer	3.54e-05	0.000567	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NAT2—liver cancer	3.5e-05	0.00056	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	3.41e-05	0.000546	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GLUL—liver cancer	3.36e-05	0.000538	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CPT1B—liver cancer	3.36e-05	0.000538	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALDOB—liver cancer	3.36e-05	0.000537	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—UGDH—liver cancer	3.33e-05	0.000534	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTA4—liver cancer	3.24e-05	0.000519	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NR1H4—liver cancer	3.24e-05	0.000518	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CRABP1—liver cancer	3.2e-05	0.000513	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—HRAS—liver cancer	3.18e-05	0.00051	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTA3—liver cancer	3.18e-05	0.00051	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.17e-05	0.000507	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	3.16e-05	0.000507	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTA2—liver cancer	3.16e-05	0.000506	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—EPT1—liver cancer	3.13e-05	0.000502	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTA1—liver cancer	3.05e-05	0.000488	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—IL6—liver cancer	3.05e-05	0.000488	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NAT2—liver cancer	3.01e-05	0.000483	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TAT—liver cancer	2.97e-05	0.000476	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—MAPK14—liver cancer	2.94e-05	0.000471	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTA4—liver cancer	2.91e-05	0.000466	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	2.9e-05	0.000465	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.9e-05	0.000464	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ALDOB—liver cancer	2.89e-05	0.000463	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—F2—liver cancer	2.85e-05	0.000456	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.85e-05	0.000456	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTA2—liver cancer	2.84e-05	0.000454	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—AKT1—liver cancer	2.81e-05	0.00045	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—HPGDS—liver cancer	2.8e-05	0.000448	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CRABP1—liver cancer	2.76e-05	0.000441	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	2.76e-05	0.000441	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTA1—liver cancer	2.74e-05	0.000438	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CG—liver cancer	2.73e-05	0.000437	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NAT2—liver cancer	2.71e-05	0.000433	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.6e-05	0.000417	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALDOB—liver cancer	2.59e-05	0.000415	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PSMD10—liver cancer	2.49e-05	0.000399	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PSMA4—liver cancer	2.49e-05	0.000399	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.48e-05	0.000397	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CRABP1—liver cancer	2.48e-05	0.000396	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	2.47e-05	0.000396	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GOT2—liver cancer	2.43e-05	0.000388	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HPGDS—liver cancer	2.41e-05	0.000386	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CD—liver cancer	2.4e-05	0.000384	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.4e-05	0.000384	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SERPINE1—liver cancer	2.37e-05	0.00038	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP2E1—liver cancer	2.28e-05	0.000365	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.23e-05	0.000357	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.18e-05	0.000349	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HPGDS—liver cancer	2.16e-05	0.000346	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.15e-05	0.000344	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PSMD10—liver cancer	2.15e-05	0.000344	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PSMA4—liver cancer	2.15e-05	0.000344	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—RAF1—liver cancer	2.14e-05	0.000343	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYCS—liver cancer	2.13e-05	0.000342	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GGT1—liver cancer	2.09e-05	0.000335	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GOT1—liver cancer	2.09e-05	0.000335	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GOT2—liver cancer	2.09e-05	0.000335	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CB—liver cancer	2.09e-05	0.000335	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CPT1B—liver cancer	2.02e-05	0.000323	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GLUL—liver cancer	2.02e-05	0.000323	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	2.02e-05	0.000323	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP2E1—liver cancer	1.96e-05	0.000315	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.96e-05	0.000314	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NR1H4—liver cancer	1.95e-05	0.000312	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.93e-05	0.00031	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PSMA4—liver cancer	1.93e-05	0.000309	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PSMD10—liver cancer	1.93e-05	0.000309	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IL2—liver cancer	1.92e-05	0.000307	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTA3—liver cancer	1.91e-05	0.000306	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.9e-05	0.000305	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTP1—liver cancer	1.88e-05	0.000301	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GOT2—liver cancer	1.88e-05	0.0003	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—HMOX1—liver cancer	1.86e-05	0.000297	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	1.85e-05	0.000297	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYCS—liver cancer	1.84e-05	0.000294	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GOT1—liver cancer	1.8e-05	0.000289	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GGT1—liver cancer	1.8e-05	0.000289	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP2E1—liver cancer	1.76e-05	0.000282	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTA4—liver cancer	1.75e-05	0.00028	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTM1—liver cancer	1.73e-05	0.000277	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.71e-05	0.000273	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTA2—liver cancer	1.71e-05	0.000273	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYCS—liver cancer	1.65e-05	0.000264	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTA1—liver cancer	1.65e-05	0.000264	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP1A1—liver cancer	1.64e-05	0.000262	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—VEGFA—liver cancer	1.63e-05	0.000261	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NAT2—liver cancer	1.63e-05	0.000261	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTP1—liver cancer	1.62e-05	0.000259	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GGT1—liver cancer	1.62e-05	0.000259	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GOT1—liver cancer	1.62e-05	0.000259	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HMOX1—liver cancer	1.6e-05	0.000256	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALDOB—liver cancer	1.56e-05	0.00025	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—MTHFR—liver cancer	1.53e-05	0.000245	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PPARA—liver cancer	1.5e-05	0.00024	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TGFB1—liver cancer	1.5e-05	0.00024	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTM1—liver cancer	1.49e-05	0.000238	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CRABP1—liver cancer	1.49e-05	0.000238	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTP1—liver cancer	1.45e-05	0.000233	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HMOX1—liver cancer	1.43e-05	0.00023	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP1A1—liver cancer	1.41e-05	0.000226	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—KRAS—liver cancer	1.39e-05	0.000222	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTM1—liver cancer	1.34e-05	0.000214	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MTHFR—liver cancer	1.32e-05	0.000211	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HPGDS—liver cancer	1.3e-05	0.000208	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PPARA—liver cancer	1.29e-05	0.000207	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CG—liver cancer	1.28e-05	0.000206	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CA—liver cancer	1.27e-05	0.000204	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP1A1—liver cancer	1.27e-05	0.000203	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PPARG—liver cancer	1.24e-05	0.000198	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TP53—liver cancer	1.23e-05	0.000197	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MTHFR—liver cancer	1.18e-05	0.000189	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—HRAS—liver cancer	1.18e-05	0.000189	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.16e-05	0.000186	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PSMA4—liver cancer	1.16e-05	0.000186	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PSMD10—liver cancer	1.16e-05	0.000186	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PPARA—liver cancer	1.16e-05	0.000186	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CD—liver cancer	1.13e-05	0.000181	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GOT2—liver cancer	1.13e-05	0.000181	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALB—liver cancer	1.11e-05	0.000178	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CG—liver cancer	1.11e-05	0.000177	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PPARG—liver cancer	1.07e-05	0.000171	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP2E1—liver cancer	1.06e-05	0.00017	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.04e-05	0.000167	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—AKT1—liver cancer	1.04e-05	0.000167	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CG—liver cancer	9.92e-06	0.000159	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYCS—liver cancer	9.92e-06	0.000159	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CB—liver cancer	9.84e-06	0.000157	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GGT1—liver cancer	9.74e-06	0.000156	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GOT1—liver cancer	9.74e-06	0.000156	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CD—liver cancer	9.72e-06	0.000156	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PPARG—liver cancer	9.58e-06	0.000153	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTP1—liver cancer	8.75e-06	0.00014	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CD—liver cancer	8.72e-06	0.00014	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HMOX1—liver cancer	8.63e-06	0.000138	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALB—liver cancer	8.61e-06	0.000138	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CB—liver cancer	8.47e-06	0.000136	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTM1—liver cancer	8.04e-06	0.000129	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP1A1—liver cancer	7.62e-06	0.000122	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CB—liver cancer	7.6e-06	0.000122	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MTHFR—liver cancer	7.1e-06	0.000114	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PPARA—liver cancer	6.97e-06	0.000112	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CA—liver cancer	6e-06	9.6e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CG—liver cancer	5.97e-06	9.56e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PPARG—liver cancer	5.76e-06	9.22e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CD—liver cancer	5.25e-06	8.4e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALB—liver cancer	5.18e-06	8.29e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CA—liver cancer	5.16e-06	8.27e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—AKT1—liver cancer	4.9e-06	7.84e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CA—liver cancer	4.64e-06	7.42e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CB—liver cancer	4.57e-06	7.32e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—AKT1—liver cancer	4.22e-06	6.75e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—AKT1—liver cancer	3.79e-06	6.06e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CA—liver cancer	2.79e-06	4.46e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—AKT1—liver cancer	2.28e-06	3.65e-05	CbGpPWpGaD
